APR 28·Trend Hunter▲
Potent Cannabis Portfolio Expansions
Aurora Cannabis has significantly expanded its global medical cannabis product line across Canada, Europe, and Australia, introducing a variety of high-potency dried flowers, pre-rolls, and multi-cannabinoid pastilles. This expansion highlights a trend towards high-potency, diverse cannabinoid formulations, and standardized product launches in regulated international markets. The move signals shifts in medical cannabis manufacturing towards precision and specialization, with implications for pharmaceutical distribution, logistics, and advanced packaging and testing solutions.
APR 15·Coast Reporter▲
Aurora Cannabis Inc. buys Safari Flower Co. in $26.5M deal
Aurora Cannabis Inc. has acquired Safari Flower Co. in a stock-and-cash deal worth $26.5 million, which includes a contingent $2 million cash payment. This acquisition provides Aurora with an EU GMP certified indoor cultivation and manufacturing facility in Ontario, aiming to boost its capacity for international medical cannabis markets like Germany, Australia, Poland, and the United Kingdom. Aurora's executive chair Miguel Martin stated that this move is a significant step in growing the company's international medical cannabis business and increasing its global market share.